SLU-PP-332 250mcg x 100ct Summary Description: SLU-PP-332 is a synthetic pan estrogen receptor-related receptor (ERR?/?/?) agonist optimized for high potency toward ERR
(PubMed) Russell RM, Suter PM
However, the relevance of these findings to humans remains uncertain, as human thyroid C-cells have much lower expression of GLP-1 receptors compared to rodents
Key Takeaways While both contain semaglutide, Wegovy is approved specifically for weight management, whereas Ozempic is approved for the treatment of type 2 diabetes
Have Type 2 diabetes and want additional cardiovascular protection
In newly diagnosed type 2 diabetic patients, a 3-month trial showed significant reductions in hemoglobin A1c (HbA1c), fasting blood glucose, and postprandial glucose levels, comparable to metformin